Results 11 to 20 of about 112,825,263 (146)

Roles of the CLEC-2–podoplanin interaction in tumor progression

open access: yesPlatelets, 2018
Podoplanin is a type-I transmembrane sialomucin-like glycoprotein expressed on the surface of several kinds of tumor cells. The podoplanin receptor is a platelet activation receptor known as C-type lectin-like receptor 2 (CLEC-2), which has been ...
Katsue Suzuki-Inoue
doaj   +4 more sources

The podoplanin-CLEC-2 axis inhibits inflammation in sepsis [PDF]

open access: yesNature Communications, 2017
Sepsis is a life-threatening condition where exaggerated inflammatory responses lead to severe tissue damage. Here, Rayes and colleagues show that the interaction between podoplanin and its receptor CLEC-2 on platelets plays a critical role in limiting ...
Julie Rayes   +9 more
doaj   +5 more sources

Platelet CLEC‐2 and lung development [PDF]

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2020
In this article, the State of the Art lecture “Platelet CLEC‐2 and Lung Development” presented at the ISTH congress 2019 is reviewed. During embryonic development, blood cells are often considered as porters of nutrition and oxygen but not as active ...
Katsue Suzuki‐Inoue, Nagaharu Tsukiji
doaj   +3 more sources

Das Hühner CLEC-2 Homolog [PDF]

open access: yes, 2012
Das Hühner CLEC-2 Homolog: Ein Thrombozytenrezeptor mit aktivierender Funktion Der Natürliche Killer Gen Komplex (NKC) des Huhnes ist auf dem Chromosom 1 lokalisiert und weist zwei C-typ Lektine auf, von denen das eine als Homolog zu CD69 und das andere
Neulen, Marie-Luise
core   +3 more sources

Katacine is a new ligand of CLEC-2 that acts as a platelet agonist [PDF]

open access: yesThrombosis and Haemostasis, 2022
Background: CLEC-2 is a platelet receptor with an important role in thrombo-inflammation but a minor role in haemostasis. Two endogenous ligands of CLEC-2 have been identified, the transmembrane protein podoplanin, and iron-containing porphyrin hemin ...
Di, Ying   +48 more
core   +4 more sources

A pull-down and slot blot-based screening system for inhibitor compounds of the podoplanin-CLEC-2 interaction.

open access: yesPLoS ONE, 2019
Podoplanin, a transmembrane glycoprotein, is overexpressed in certain types of tumors and induces platelet aggregation by binding to C-type lectin-like receptor 2 (CLEC-2) on the platelet membrane. Activated platelets release granule components, which in
Nobuo Watanabe   +10 more
doaj   +2 more sources

Thrombomodulation via CLEC-2 targeting.

open access: yesCurrent Opinion in Pharmacology, 2009
CLEC-2 is a C-type lectin-like molecule that has recently been identified as a receptor on the surface of platelets. Ligand binding by CLEC-2 promotes phosphorylation of a tyrosine in the cytoplasmic domain YXXL motif of CLEC-2 by Src kinases and further
Chris A O’Callaghan
core   +4 more sources

Platelet CLEC-2: Roles Beyond Hemostasis

open access: yesSeminars in Thrombosis and Hemostasis, 2017
C-type lectin-like receptor 2 (CLEC-2) has been identified on the surface of platelets as a receptor for a platelet activating snake venom, rhodocytin/aggretin.
Yukio Ozaki   +5 more
core   +3 more sources

The role of CLEC-2 in and beyond the vasculature

open access: yes, 2017
C-type lectin-like receptor 2 (CLEC-2) is a glycoprotein expressed on the surface of platelets that induces platelet activation including aggregation.
Alexander T. Hardy   +11 more
core   +2 more sources

PDGF upregulates CLEC-2 to induce T regulatory cells [PDF]

open access: yesOncotarget, 2015
The effect of platelet derived growth factor (PDGF) on immune cells is not elucidated. Here, we demonstrate PDGF inhibited the maturation of human DCs and induced IL-10 secretion.
Agrawal, Anshu   +9 more
core   +6 more sources

Home - About - Disclaimer - Privacy